{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:16:46Z","timestamp":1790003806180,"version":"4.0.1"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:00:00Z","timestamp":1510185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["RC1AI048874-01 and UC1AI049499-01"],"award-info":[{"award-number":["RC1AI048874-01 and UC1AI049499-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GSK"},{"name":"US Army Medical Research and Material Command"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0187376","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T18:50:09Z","timestamp":1510253409000},"page":"e0187376","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5337-8937","authenticated-orcid":true,"given":"Mark M.","family":"Fukuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srivicha","family":"Krudsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadeeja","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhuma","family":"Warrasak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Noedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ataya","family":"Euswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mali","family":"Ittiverakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nillawan","family":"Buathong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabaithip","family":"Sriwichai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Scott","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Ohrt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"key":"ref1","article-title":"World malaria report [Internet]","year":"2016"},{"issue":"9754","key":"ref2","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/S0140-6736(10)60831-8","article-title":"Adult and child malaria mortality in India: a nationally representative mortality survey","volume":"376","author":"N Dhingra","year":"2010","journal-title":"Lancet"},{"issue":"6 Suppl","key":"ref3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4269\/ajtmh.16-0141","article-title":"Global epidemiology of <italic>Plasmodium vivax<\/italic>","volume":"95","author":"RE Howes","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"ref4","article-title":"Control and elimination of <italic>Plasmodium vivax<\/italic> malaria: a technical brief [Internet]","year":"2015"},{"issue":"6 Suppl","key":"ref5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4269\/ajtmh.16-0093","article-title":"Epidemiology of <italic>Plasmodium vivax<\/italic> in Indonesia","volume":"95","author":"C Surjadjaja","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"ref6","article-title":"Guidelines for the treatment of malaria","year":"2015"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1475-2875-11-280","article-title":"Primaquine radical cure of <italic>Plasmodium vivax<\/italic>: a critical review of the literature","volume":"11","author":"GK John","year":"2012","journal-title":"Malaria journal"},{"issue":"9922","key":"ref8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(13)62568-4","article-title":"Tafenoquine plus chloroquine for the treatment and relapse prevention of <italic>Plasmodium vivax<\/italic> malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study","volume":"383","author":"A Llanos-Cuentas","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/13543784.16.5.705","article-title":"Tafenoquine: a promising new antimalarial agent","volume":"16","author":"M Crockett","year":"2007","journal-title":"Expert opinion on investigational drugs"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/367542","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against <italic>Plasmodium falciparum<\/italic>","volume":"36","author":"BR Hale","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1086\/324081","article-title":"A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against <italic>Plasmodium falciparum<\/italic> malaria","volume":"33","author":"GD Shanks","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"9220","key":"ref12","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(00)02352-7","article-title":"Malaria chemoprophylaxis with tafenoquine: a randomised study","volume":"355","author":"B Lell","year":"2000","journal-title":"Lancet"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1086\/424468","article-title":"Efficacy of monthly tafenoquine for prophylaxis of <italic>Plasmodium vivax<\/italic> and multidrug-resistant <italic>P<\/italic>. <italic>falciparum<\/italic> malaria","volume":"190","author":"DS Walsh","year":"2004","journal-title":"The Journal of infectious diseases"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1086\/424508","article-title":"Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing <italic>Plasmodium vivax<\/italic> malaria relapse","volume":"39","author":"DS Walsh","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1086\/315034","article-title":"Randomized dose-ranging study of the safety and efficacy of WR 238605 (tafenoquine) in the prevention of relapse of <italic>Plasmodium vivax<\/italic> malaria in Thailand","volume":"180","author":"DS Walsh","year":"1999","journal-title":"The Journal of infectious diseases"},{"issue":"4","key":"ref16","first-page":"CD010458","article-title":"Tafenoquine for preventing relapse in people with <italic>Plasmodium vivax<\/italic> malaria","author":"S Rajapakse","year":"2015","journal-title":"The Cochrane database of systematic reviews"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4269\/ajtmh.1997.56.508","article-title":"WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of <italic>Plasmodium vivax<\/italic> in <italic>Aotus<\/italic> monkeys","volume":"56","author":"N Obaldia 3rd","year":"1997","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0001-706X(02)00289-9","article-title":"Blood schizontocidal activity of WR 238605 (tafenoquine) against <italic>Plasmodium cynomolgi<\/italic> and <italic>Plasmodium fragil<\/italic>e infections in rhesus monkeys","volume":"86","author":"SK Puri","year":"2003","journal-title":"Acta tropica"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archinte.1962.03620140081013","article-title":"Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance","volume":"109","author":"AR Tarlov","year":"1962","journal-title":"Archives of internal medicine"},{"key":"ref20","article-title":"Haemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol variant) versus G6PD-normal volunteers","author":"R Rueangweerayut","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4269\/ajtmh.2009.80.188","article-title":"Methemoglobinemia and adverse events in <italic>Plasmodium vivax<\/italic> malaria patients associated with high doses of primaquine treatment","volume":"80","author":"J Carmona-Fonseca","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/AAC.00354-09","article-title":"Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects","volume":"54","author":"PE Nasveld","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4269\/ajtmh.2009.81.356","article-title":"A randomized, double-blind, safety and tolerability study to assess the ophthalmic and renal effects of tafenoquine 200 mg weekly versus placebo for 6 months in healthy volunteers","volume":"81","author":"KJ Leary","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/AAC.00903-07","article-title":"Pharmacokinetic determinants of the window of selection for antimalarial drug resistance","volume":"52","author":"K Stepniewska","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12936-015-0810-4","article-title":"Measuring windows of selection for anti-malarial drug treatments","volume":"14","author":"K Kay","year":"2015","journal-title":"Malaria journal"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0187376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:58:20Z","timestamp":1589025500000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0187376"}},"subtitle":[],"editor":[{"given":"David Joseph","family":"Diemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0187376","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]}}}